SEC Form 6-K filed by Bright Minds Biosciences Inc.
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
Form 6-K
REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934
For the month of October 2024
Commission File Number: 001-40997
Bright Minds Biosciences Inc.
(Translation of registrant's name into English)
19 Vestry Street
New York, NY 10013
(Address of principal executive office)
Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F
Form 20-F [ X ] Form 40-F [ ]
SUBMITTED HEREWITH
| Exhibit | ||
| 99.1 | Press Release dated October 16, 2024 |
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.
| Bright Minds Biosciences Inc. | ||
| Date: October 16, 2024 | /s/ Ryan Cheung | |
| Ryan Cheung | ||
| Chief Financial Officer | ||